Memory: Forget me not
It’s great when our memory of some past event, if challenged by someone else with a different memory of it, is vindicated. Often we will simply be pleased to be right, but in some cases (such as a court of law), being right will be a matter of some importance. It must also be pleasing if you are a scientist with a theory about memory that is vindicated after being challenged by other scientists. For over 20 years, Todd Sacktor of the State University of New York (SUNY) Downstate Medical Center has been building a theory about an enzyme that he believes to be at the heart of the molecular mechanism of long-term memory. Two papers published in 2013 led many researchers to doubt this proposal but now, in eLife, Sacktor reports the results of experiments that provide new evidence that supports his theory (Tsokas et al., 2016).
The issue in question centres on how permanent memories are formed in the brain. Francis Crick wrote about memory and molecular turnover, and John Lisman developed the idea of an auto-catalytic molecule that, after an initial trigger, self-replicated its active state in the absence of further input. It is generally agreed that memory involves strengthening the synapses that connect neurons in specific parts of the brain. Sacktor has argued that this strengthening may be mediated by a lasting increase in the level of an isoform of an enzyme called PKMζ (pronounced PKM zeta) that can be rendered inherently active.
Evidence in support of this notion comes from the fact that PKMζ is known to increase the strength of synapses and, moreover, to be produced by neurons during learning. Furthermore, using a drug called ZIP (short for zeta inhibitory peptide) that inhibits the action of PKMζ prevented the formation of long-term memories (Pastalkova et al., 2006), as did the use of genetic techniques to suppress the production of PKMζ (Shema et al, 2011).
Unfortunately, in 2013, independent groups at Johns Hopkins University (Volk et al., 2013) and UCSF (Lee et al., 2013) reported that mice in which the gene for PKMζ had been knocked out were still able to form long-term memories. Moreover, they showed that while ZIP did indeed abolish memory in wild-type mice, it also abolished memories in the knock-out mice. These papers were widely discussed in the neuroscience community, with the bar-room gossip being that they had demolished Sacktor’s theory, although some researchers sought to defend his position by wondering about “redundancy and degeneracy” in the nervous system (Frankland and Josselyn, 2013). Of course, gossip should be treated with caution, as new results from Sacktor, Andre Fenton of New York University and co-workers – including Panayiotis Tsokas of SUNY as first author – suggest that a different enzyme, PKCι/λ (pronounced PKM iota lambda), is up-regulated in the absence of PKMζ and may take over some of its functions (Tsokas et al., 2016).
The researchers studied a phenomenon called long-term potentiation (LTP): this is a persistent increase in the strength of synapses and it results in the increased transmission of signals between neurons. LTP is considered to be one of the mechanisms that is responsible for learning and memory. Tsokas et al. observed that ZIP reduced late-LTP in PKMζ null mice: however, this happened because ZIP also inhibits the self-sustaining function of PKCι/λ. To explore this further Tsokas et al. created a new antisense molecule that targets the translation start site of PKMζ, predicting it would reduce late-LTP in wild-type mice but not in null mice. This prediction was upheld and validated biochemically. Additionally, while the level of PKCι/λ only increases transiently after the induction of LTP in wild-type mice (because PKMζ is doing the memory work), its level remained high throughout the experiments with the null mice. Symmetrically, a different molecule called ICAP that acts on PKCι/λ but not on PKMζ reversed late-LTP in the null mice but not in wild-type mice.
Behavioural studies using a place avoidance task by Tsokas et al. revealed that the antisense molecule disrupted long-term memory in wild-type mice but not in null mice, and that ICAP disrupted long-term memory in the null mice. A slight shadow is cast on the elegance of the story in that PKCι/λ does not perfectly compensate for lost PKMζ in vivo. Unexpected subtle differences were also observed in the behavioural strategies assumed by the wild-type and PKMζ null mice.
One nagging concern is whether a molecule implicated in memory retention really does need to be sustained throughout the lifetime of a memory. An alternative possibility is that it may trigger structural changes that are, in turn, mediated by other molecules (such as actin): thus, with this job done, our memory molecule can gracefully depart the scene to play upon another stage. Such structural changes could then be faithfully recycled during routine protein turnover, with these proteins being unaware, so to speak, that they are sustaining a memory.
A speculative analogy might be helpful here. Consider a spacecraft that is orbiting the earth before it is sent to the moon. For a brief period, the engines are activated, the rocket speeds up, and the spacecraft escapes earth’s gravity. It is on its way to the moon. The engines are then stopped and the rocket keeps going. Should we look for ‘molecules’ that sustain its motion towards the moon, akin to maintaining a memory as in Sacktor’s argument? Newton’s first law of motion tells us that the rocket will keep moving through space at the same velocity without help from anything else. By analogy, the molecules that make it possible for memories to be retained over long periods of time could, like the engines on a rocket, be activated only transiently. For now, the star billing for PKMζ seems to be vindicated, but time will tell whether this is sustained or transient.
References
Article and author information
Author details
Publication history
Copyright
© 2016, Morris
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,381
- views
-
- 276
- downloads
-
- 6
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Neuroscience
The concept that dimeric protein complexes in synapses can sequentially replace their subunits has been a cornerstone of Francis Crick’s 1984 hypothesis, explaining how long-term memories could be maintained in the face of short protein lifetimes. However, it is unknown whether the subunits of protein complexes that mediate memory are sequentially replaced in the brain and if this process is linked to protein lifetime. We address these issues by focusing on supercomplexes assembled by the abundant postsynaptic scaffolding protein PSD95, which plays a crucial role in memory. We used single-molecule detection, super-resolution microscopy and MINFLUX to probe the molecular composition of PSD95 supercomplexes in mice carrying genetically encoded HaloTags, eGFP, and mEoS2. We found a population of PSD95-containing supercomplexes comprised of two copies of PSD95, with a dominant 12.7 nm separation. Time-stamping of PSD95 subunits in vivo revealed that each PSD95 subunit was sequentially replaced over days and weeks. Comparison of brain regions showed subunit replacement was slowest in the cortex, where PSD95 protein lifetime is longest. Our findings reveal that protein supercomplexes within the postsynaptic density can be maintained by gradual replacement of individual subunits providing a mechanism for stable maintenance of their organization. Moreover, we extend Crick’s model by suggesting that synapses with slow subunit replacement of protein supercomplexes and long-protein lifetimes are specialized for long-term memory storage and that these synapses are highly enriched in superficial layers of the cortex where long-term memories are stored.
-
- Neuroscience
Motivation depends on dopamine, but might be modulated by acetylcholine which influences dopamine release in the striatum, and amplifies motivation in animal studies. A corresponding effect in humans would be important clinically, since anticholinergic drugs are frequently used in Parkinson’s disease, a condition that can also disrupt motivation. Reward and dopamine make us more ready to respond, as indexed by reaction times (RT), and move faster, sometimes termed vigour. These effects may be controlled by preparatory processes that can be tracked using electroencephalography (EEG). We measured vigour in a placebo-controlled, double-blinded study of trihexyphenidyl (THP), a muscarinic antagonist, with an incentivised eye movement task and EEG. Participants responded faster and with greater vigour when incentives were high, but THP blunted these motivational effects, suggesting that muscarinic receptors facilitate invigoration by reward. Preparatory EEG build-up (contingent negative variation [CNV]) was strengthened by high incentives and by muscarinic blockade, although THP reduced the incentive effect. The amplitude of preparatory activity predicted both vigour and RT, although over distinct scalp regions; frontal activity predicted vigour, whereas a larger, earlier, central component predicted RT. The incentivisation of RT was partly mediated by the CNV, though vigour was not. Moreover, the CNV mediated the drug’s effect on dampening incentives, suggesting that muscarinic receptors underlie the motivational influence on this preparatory activity. Taken together, these findings show that a muscarinic blocker impairs motivated action in healthy people, and that medial frontal preparatory neural activity mediates this for RT.